2.81 B
About ONCOSIL MEDICAL LIMITED
Sector
Industry
CEO
Nigel Lange
Website
Headquarters
Macquarie Park
Founded
2005
ISIN
AU0000325565
FIGI
BBG01M33P5R2
OncoSil Medical Ltd. develops and commercializes neurology services, including those for pancreatic cancer. It engages in the development of novel and safer radiation therapy treatments. The company was founded by David McAuliffe on April 14, 2005 and is headquartered in North Sydney, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange ONCOSIL MEDICAL LIMITED stocks are traded under the ticker OSLN.
Yes, you can track ONCOSIL MEDICAL LIMITED financials in yearly and quarterly reports right on TradingView.
No, OSLN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, OSLN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ONCOSIL MEDICAL LIMITED stock right from TradingView charts — choose your broker and connect to your account.